105 Participants Needed

Negative Pressure Wound Therapy for Knee and Hip Replacement

Recruiting at 10 trial locations
JO
Overseen ByJennifer O'Connell, Sr. Clinical Project Manager
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Molnlycke Health Care AB
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 3 JurisdictionsThis treatment is already approved in other countries

Trial Summary

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial investigators.

What data supports the effectiveness of the treatment Avance Solo Negative Pressure Wound Therapy for knee and hip replacement?

Research shows that negative pressure wound therapy (NPWT), like Avance Solo, helps wounds heal by using a vacuum to remove fluid and increase blood flow. It's been used successfully to prevent infections and complications in surgeries, including hip replacements and lower extremity fractures, suggesting it could be effective for knee and hip replacements too.12345

Is Negative Pressure Wound Therapy safe for knee and hip replacement surgeries?

Negative Pressure Wound Therapy (NPWT) is generally safe, but it may cause more blisters in patients after total knee arthroplasty. It helps reduce superficial surgical site infections, and no significant differences in total complications were found compared to standard treatments.12367

How is the Avance Solo Negative Pressure Wound Therapy treatment different from other treatments for knee and hip replacement?

The Avance Solo Negative Pressure Wound Therapy is unique because it is a portable, single-use system that allows patients to continue their treatment at home, promoting mobility and freedom while reducing hospital stay. It uses a vacuum dressing to help wounds heal by drawing out fluid and increasing blood flow, and it includes Safetac® adhesive technology to minimize pain during dressing changes.12358

What is the purpose of this trial?

Interventional study exploring surgical site complication occurrences in high-risk revision patients undergoing TKA or THA using NPWT.

Eligibility Criteria

This trial is for high-risk patients who are undergoing a second (revision) knee or hip replacement surgery. It's not specified who can't join the trial, but typically, people with certain health conditions or those who don't meet the study requirements would be excluded.

Inclusion Criteria

High-risk patients for surgical wound complications as determined by investigators
Written informed consent
Patients must understand how to operate the negative pressure system at home
See 4 more

Exclusion Criteria

Subjects with contraindications as per the Avance Solo Instructions for use
Clinically significant conditions that would impair the subject's ability to comply with the study
Known allergies to product components (silicone adhesives, polyurethane films, acrylic adhesives, polyethylene fabrics, superabsorbent powders)
See 11 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Surgery and Treatment

Participants undergo revision of total hip or knee joint arthroplasty and receive closed incision negative pressure wound therapy

Immediate post-surgery period

Follow-up

Participants are monitored for surgical site complications and infections

12 weeks

Treatment Details

Interventions

  • Avance Solo Negative Pressure Wound Therapy
Trial Overview The study is testing whether using Avance Solo Negative Pressure Wound Therapy (NPWT) can reduce surgical site infections in patients having revision total knee or hip replacements.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: Avance Solo ciNPTExperimental Treatment1 Intervention

Avance Solo Negative Pressure Wound Therapy is already approved in United States, European Union for the following indications:

🇺🇸
Approved in United States as Avance Solo for:
  • Closed surgical incisions
  • Acute and chronic open wounds
  • Pressure ulcers
🇪🇺
Approved in European Union as Avance Solo for:
  • Closed surgical incisions
  • Acute and chronic open wounds
  • Pressure ulcers

Find a Clinic Near You

Who Is Running the Clinical Trial?

Molnlycke Health Care AB

Lead Sponsor

Trials
57
Recruited
7,900+

Findings from Research

Negative-pressure wound therapy (NPWT) is effective in promoting healing for various wound types and is increasingly used in homecare settings due to portable devices, allowing for earlier patient discharge from hospitals.
The Avance Solo system, a single-patient-use NPWT device, enhances patient mobility and comfort while minimizing pain during dressing changes, demonstrating its potential to improve quality of life during multi-week treatments.
A portable, disposable system for negative-pressure wound therapy.Brandon, T.[2015]
In a pilot study involving 70 patients undergoing elective hip arthroplasty, negative-pressure wound therapy (NPWT) showed a slight reduction in surgical site infection (SSI) rates compared to standard dressings, but the difference was not statistically significant (2 vs 3 infections).
However, patients using NPWT experienced a higher rate of postoperative wound complications, indicating that while NPWT may have some benefits, it could also lead to more issues, suggesting the need for a larger trial to better assess its efficacy.
Use of Negative-Pressure Wound Dressings to Prevent Surgical Site Complications After Primary Hip Arthroplasty: A Pilot RCT.Gillespie, BM., Rickard, CM., Thalib, L., et al.[2022]
In a pilot study involving 60 patients undergoing major foot and ankle surgery, the use of a portable negative pressure wound therapy (NPWT) device resulted in a 7.5% rate of surgical site infections, which included both superficial and deep infections.
The incidence of surgical site infections with NPWT did not show a statistically significant reduction compared to a matched historical cohort, suggesting that while NPWT is feasible, it may not provide a clear advantage in preventing infections in this patient population.
Prophylactic negative pressure wound therapy after lower extremity fracture surgery: a pilot study.Dingemans, SA., Birnie, MFN., Backes, M., et al.[2019]

References

A portable, disposable system for negative-pressure wound therapy. [2015]
Use of Negative-Pressure Wound Dressings to Prevent Surgical Site Complications After Primary Hip Arthroplasty: A Pilot RCT. [2022]
Prophylactic negative pressure wound therapy after lower extremity fracture surgery: a pilot study. [2019]
Incisional negative pressure wound therapy after high-risk lower extremity fractures. [2022]
Negative Pressure, a "Solution" in the Treatment of Infected Knee Prosthesis? [2022]
Negative pressure wound therapy in patients with wounds healing by secondary intention: a systematic review and meta-analysis of randomised controlled trials. [2021]
Negative pressure wound therapy in total hip and knee arthroplasty: a meta-analysis. [2020]
Postoperative wound management with negative pressure wound therapy in knee and hip surgery: a randomised control trial. [2018]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security